BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 37024866)

  • 1. Identification of hub genes and pathways in lung metastatic colorectal cancer.
    Dai W; Guo C; Wang Y; Li Y; Xie R; Wu J; Yao B; Xie D; He L; Li Y; Huang H; Wang Y; Liu S
    BMC Cancer; 2023 Apr; 23(1):323. PubMed ID: 37024866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The identification of a common different gene expression signature in patients with colorectal cancer.
    Zhao ZW; Fan XX; Yang LL; Song JJ; Fang SJ; Tu JF; Chen MJ; Zheng LY; Wu FZ; Zhang DK; Ying XH; Ji JS
    Math Biosci Eng; 2019 Apr; 16(4):2942-2958. PubMed ID: 31137244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating the underlying molecular mechanisms and key genes involved in metastasis of colorectal cancer via bioinformatics analysis.
    Qi C; Chen Y; Zhou Y; Huang X; Li G; Zeng J; Ruan Z; Xie X; Zhang J
    Oncol Rep; 2018 May; 39(5):2297-2305. PubMed ID: 29517105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Core Genes and Pathways in Melanoma Metastasis via Bioinformatics Analysis.
    Xie R; Li B; Jia L; Li Y
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of potential biomarkers with colorectal cancer based on bioinformatics analysis and machine learning.
    Hammad A; Elshaer M; Tang X
    Math Biosci Eng; 2021 Oct; 18(6):8997-9015. PubMed ID: 34814332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer.
    Ebadfardzadeh J; Kazemi M; Aghazadeh A; Rezaei M; Shirvaliloo M; Sheervalilou R
    Med Oncol; 2021 Aug; 38(9):114. PubMed ID: 34390411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential therapeutic targets associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Sharma A; Yadav D; Rao P; Sinha S; Goswami D; Rawal RM; Shrivastava N
    Comput Biol Med; 2022 Jul; 146():105688. PubMed ID: 35680454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
    Yu C; Chen F; Jiang J; Zhang H; Zhou M
    Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.
    Chang H; Jin L; Xie P; Zhang B; Yu M; Li H; Liu S; Yan J; Zhou B; Li X; Xu Y; Xiao Y; Ye Q; Guo L
    J Gastrointest Oncol; 2022 Oct; 13(5):2351-2365. PubMed ID: 36388659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatic Identification of Hub Genes and Analysis of Prognostic Values in Colorectal Cancer.
    Lei X; Jing J; Zhang M; Guan B; Dong Z; Wang C
    Nutr Cancer; 2021; 73(11-12):2568-2578. PubMed ID: 33153324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key pathways and genes in colorectal cancer using bioinformatics analysis.
    Liang B; Li C; Zhao J
    Med Oncol; 2016 Oct; 33(10):111. PubMed ID: 27581154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics approach to unwind key genes and pathways involved in colorectal cancer.
    Mobeen SA; Saxena P; Jain AK; Deval R; Riazunnisa K; Pradhan D
    J Cancer Res Ther; 2023 Oct; 19(7):1766-1774. PubMed ID: 38376276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis.
    Li J; Wang Y; Wang X; Yang Q
    World J Surg Oncol; 2020 Mar; 18(1):50. PubMed ID: 32127012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
    Li F; Guo P; Dong K; Guo P; Wang H; Lv X
    J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating potential molecular mechanisms of serum exosomal miRNAs in colorectal cancer based on bioinformatics analysis.
    Wang H; Chen X; Bao L; Zhang X
    Medicine (Baltimore); 2020 Sep; 99(37):e22199. PubMed ID: 32925795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico analysis to identify miR-1271-5p/PLCB4 (phospholipase C Beta 4) axis mediated oxaliplatin resistance in metastatic colorectal cancer.
    Lee CC; Lee AW; Wei PL; Liu YS; Chang YJ; Huang CY
    Sci Rep; 2023 Mar; 13(1):4366. PubMed ID: 36927770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.